Cardiovascular Center, Yokosuka Kyousai Hospital, Yonegahama-dori 1-16, Yokosuka, Kanagawa, Japan 238-8558.
Circulation. 2011 Nov 29;124(22):2380-7. doi: 10.1161/CIRCULATIONAHA.111.047266. Epub 2011 Oct 31.
Kidney function is a known predictor of cardiovascular morbidity and mortality. Although patients with atrial fibrillation (AF) often have kidney dysfunction, less is known about the association between AF and kidney function. We sought to assess changes in kidney function after catheter ablation of AF.
Patients who underwent catheter ablation of AF were recruited for the present prospective study. Estimated glomerular filtration rate (eGFR) was evaluated before and 1 year after the ablation. Three hundred eighty-six patients (paroxysmal AF, 135; persistent AF, 106; longstanding persistent AF, 145) were studied. Their baseline eGFR was 68 ± 14 mL · min(-1) · 1.73 m(-2). Sixty-six percent and 26% of patients had eGFR of 60 to 89 and 30 to 59 mL · min(-1) · 1.73 m(-2), respectively. Overall, 278 patients (72%) were arrhythmia free over a 1-year follow-up. In patients free from arrhythmia, eGFR increased 3 months later and was maintained until 1 year, whereas in patients with recurrences, eGFR had decreased over 1 year. Changes in eGFR over 1 year in patients free from arrhythmia differed significantly compared with those with recurrences (3 ± 8 versus -2 ± 8 mL · min(-1) · 1.73 m(-2); P<0.0001). In all quartiles of baseline eGFR, changes in eGFR over 1 year after the ablation were greater in patients free from arrhythmia compared with those with recurrences.
Elimination of AF by catheter ablation was associated with improvement of kidney function over a 1-year follow-up in patients with mild to moderate kidney dysfunction.
肾功能是预测心血管发病率和死亡率的一个已知因素。尽管患有心房颤动(AF)的患者通常存在肾功能障碍,但关于 AF 与肾功能之间的关系知之甚少。我们旨在评估 AF 导管消融后肾功能的变化。
本前瞻性研究纳入了接受 AF 导管消融的患者。在消融前和消融后 1 年评估估算肾小球滤过率(eGFR)。研究了 386 名患者(阵发性 AF,135 例;持续性 AF,106 例;持久性 AF,145 例)。他们的基线 eGFR 为 68±14mL·min(-1)·1.73m(-2)。66%和 26%的患者 eGFR 分别为 60 至 89 和 30 至 59mL·min(-1)·1.73m(-2)。总的来说,278 名患者(72%)在 1 年随访期间无心律失常。在无心律失常的患者中,eGFR 在 3 个月后增加并持续至 1 年,而在复发的患者中,eGFR 在 1 年内下降。无心律失常患者的 eGFR 在 1 年内的变化与复发患者的变化明显不同(3±8 与-2±8mL·min(-1)·1.73m(-2);P<0.0001)。在 eGFR 基线的所有四分位中,与复发患者相比,无心律失常患者的 eGFR 在消融后 1 年内的变化更大。
在轻度至中度肾功能障碍的患者中,通过导管消融消除 AF 与 1 年随访期间肾功能的改善相关。